Principal indication for LMWH use
Indication for LMWH . | No. of studies . | No. of pregnancies . |
|---|---|---|
| Treatment of VTE | 15 | 174 |
| Thromboprophylaxis | 30 | 1321 |
| Thromboprophylaxis following VTE in index pregnancy | 5 | 27 |
| Prevention of RPL | 15 | 447 |
| Prevention of preeclampsia/IUGR | 5 | 88 |
| Unspecified prophylaxis | 6 | 720 |
| Total number of studies included in analysis | 64* | 2777 |
Indication for LMWH . | No. of studies . | No. of pregnancies . |
|---|---|---|
| Treatment of VTE | 15 | 174 |
| Thromboprophylaxis | 30 | 1321 |
| Thromboprophylaxis following VTE in index pregnancy | 5 | 27 |
| Prevention of RPL | 15 | 447 |
| Prevention of preeclampsia/IUGR | 5 | 88 |
| Unspecified prophylaxis | 6 | 720 |
| Total number of studies included in analysis | 64* | 2777 |
IUGR indicates intrauterine growth restriction.
The total number of studies (76) is greater than the total included for analysis (64) because 12 studies clearly indicated multiple indications for LMWH use in different patients.